Efficacy of propiverine hydrochloride for urinary incontinence afterlaparoscopic radical prostatectomy

Efficacy of propiverine hydrochloride for urinary incontinence afterlaparoscopic radical prostatectomy - Propiverine HCl after prostatectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040981

Enrollment

Registered

2020-07-02

Start date

2013-06-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Efficacy of propiverine hydrochloride for urinary incontinence after robot-assisted or laparoscopic radical prostatectomy

Interventions

Patients in the treatment group received propiverine hydrochloride at a dose of 20 mg/day for 6 months. Patients in the control group did not received.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients who underwent RALP or LRP at our hospital from April 2013 to December 2017 and who experienced postoperative urinary incontinence, defined as pad gain over 1 g on 1-hour pad test.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had neurogenic bladder dysfunction, overactive bladder, SUI, urinary tract infection, urethral stricture, glaucoma, severe cardiac disease, renal dysfunction, and/or hepatic dysfunction. Patients were also excluded if they received radiation therapy and/or oral treatment with anticholinergic agents, antidepressants.

Design outcomes

Primary

Measure	Time frame
The primary endpoint was the pad-test negative rate at 6 months postoperatively.	—

Countries

Japan

Contacts

Public ContactKojiro Ohba

Nagasaki University Hospital Department of Urology and Renal Transplantation

ohba-k@nagasaki-u.ac.jp+81958197340

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026